10x Genomics Inc [NASDAQ: TXG] traded at a high on 2025-06-25, posting a 6483648 gain after which it closed the day’ session at $3780000.0.
The results of the trading session contributed to over 6483648 shares changing hands. Over the past one week, the price volatility of 10x Genomics Inc stands at 3.44% while the volatility over the past one month is 3.41%.
The market cap for TXG stock reached $1.46 billion, with 109.08 million shares outstanding and 105.63 million shares in the current float. Compared to the average trading volume of 3.78M shares, TXG reached a trading volume of 6483648 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about 10x Genomics Inc [TXG]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for TXG shares is $12.93 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on TXG stock is a recommendation set at 2.26. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Leerink Partners have made an estimate for 10x Genomics Inc shares, keeping their opinion on the stock as Market Perform, with their previous recommendation back on February 13, 2025. While these analysts kept the previous recommendation, Leerink Partners raised their target price to Outperform. The new note on the price target was released on September 03, 2024, representing the official price target for 10x Genomics Inc stock. Previously, the target price had yet another raise to $24, while Jefferies analysts kept a Buy rating on TXG stock. On July 18, 2024, analysts decreased their price target for TXG shares from 40 to 20.
The Price to Book ratio for the last quarter was 2.03, with the Price to Cash per share for the same quarter was set at 3.42. Price to Free Cash Flow for TXG in the course of the last twelve months was 32.09 with Quick ratio for the last quarter at 4.68.
How has TXG stock performed recently?
10x Genomics Inc [TXG] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 10.42. With this latest performance, TXG shares gained by 42.72% in over the last four-week period, additionally sinking by -14.33% over the last 6 months – not to mention a drop of -18.80% in the past year of trading.
10x Genomics Inc [TXG]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and 10x Genomics Inc [TXG] shares currently have an operating margin of -29.01% and a Gross Margin at 70.75%. 10x Genomics Inc’s Net Margin is presently recorded at -25.14%.
Return on Equity for this stock declined to -17.20%, with Return on Assets sitting at -17.20%.
Earnings analysis for 10x Genomics Inc [TXG]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for TXG. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for 10x Genomics Inc go to 24.87%.
Insider trade positions for 10x Genomics Inc [TXG]
There are presently around $102.33%, or 104.34% of TXG stock, in the hands of institutional investors. The top three institutional holders of TXG stocks are: FMR LLC with ownership of 13.01 million shares, which is approximately 10.836%. VANGUARD GROUP INC, holding 10.19 million shares of the stock with an approximate value of $$198.18 million in TXG stocks shares; and VANGUARD GROUP INC, currently with $$181.15 million in TXG stock with ownership which is approximately 7.7571%.
